pith. sign in

arxiv: 2606.30681 · v1 · pith:ZPJSTUH7new · submitted 2026-06-27 · 🧬 q-bio.QM · nlin.PS

Pattern formation in a Reaction-Diffusion Model for Amyloid-β and Tau Interactions in Alzheimer's Disease

Sun Lee , Wenrui Hao This is my paper

Pith reviewed 2026-07-01 07:19 UTC · model grok-4.3

classification 🧬 q-bio.QM nlin.PS
keywords Alzheimer's diseaseamyloid-betatau proteinreaction-diffusionpattern formationGray-Scott modelspatial heterogeneitysteady states
0
0 comments X

The pith

Amyloid-beta and tau proteins can settle into many different stable spatial patterns rather than one fixed pathological state.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper adapts the Gray-Scott reaction-diffusion model to describe the interactions and spread of amyloid-beta and tau in brain tissue. Numerical simulations on flat domains and realistic cortical surfaces locate many distinct steady-state patterns, which are then grouped into phenotypes by principal component analysis and clustering. This matters to a sympathetic reader because it offers one explanation for why some people carry substantial pathology yet remain cognitively intact. The work also sketches a treatment idea that would steer the system toward less damaging patterns instead of only trying to clear the proteins.

Core claim

The coupled Aβ–Tau system, modeled by an adapted Gray-Scott reaction-diffusion system, admits numerous stable spatial patterns. These patterns are located with the Companion-Based Multi-Level Finite Element Method on both two-dimensional domains and anatomically realistic cortical meshes and are classified into representative phenotypes by principal component analysis and clustering. The results indicate multiple steady states rather than a single pathological endpoint, supplying a mathematical framework for the heterogeneity of Alzheimer's disease and the existence of cognitively resilient individuals despite heavy protein burden.

What carries the argument

Adapted Gray-Scott reaction-diffusion equations for Aβ-Tau kinetics, solved via Companion-Based Multi-Level Finite Element Method to locate and classify multiple steady-state spatial patterns.

If this is right

  • Disease progression depends on the spatial organization of the proteins as well as their total amounts.
  • The model accounts for individuals who exhibit substantial pathology yet remain cognitively resilient.
  • A pattern-based therapeutic approach could guide the system toward favorable stable states rather than solely eliminating the proteins.
  • The framework supplies a way to classify different pattern phenotypes observed in Alzheimer's disease.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • Brain imaging focused on spatial distributions rather than total load might improve prediction of individual outcomes.
  • The same modeling strategy could be tested on other protein-misfolding diseases that involve interacting species.
  • If reaction or diffusion parameters can be modulated, they might serve as levers to favor one pattern class over another.

Load-bearing premise

The Gray-Scott reaction-diffusion equations, after adaptation, capture the essential biological interactions and kinetics between amyloid-beta and tau well enough to produce biologically relevant stable states.

What would settle it

Direct observation that real Aβ and tau distributions in human Alzheimer's brains always converge to one specific spatial pattern regardless of starting conditions would falsify the existence of numerous stable states.

read the original abstract

Alzheimer's disease (AD) is characterized by the accumulation of Amyloid-$\beta$ ($A\beta$) plaques and hyperphosphorylated Tau proteins. However, many individuals exhibit substantial $A\beta$ and Tau pathology without developing dementia, suggesting that disease progression may depend not only on pathological burden but also on the spatial organization of these proteins. Motivated by this observation, we adapt Gray-Scott reaction-diffusion model to investigate pattern formation arising from the interactions between $A\beta$ and Tau. % To systematically identify stable spatial configurations, we employ a Companion-Based Multi-Level Finite Element Method (CBMFEM) on both two-dimensional domains and anatomically realistic cortical surface meshes. Numerical simulations reveal a rich landscape of multiple steady-state solutions, which are subsequently classified into representative pattern phenotypes using principal component analysis and clustering techniques. The results demonstrate that the coupled $A\beta$--Tau system admits numerous stable spatial patterns rather than a single pathological endpoint. % These findings provide a potential mathematical framework for understanding the heterogeneity of Alzheimer's disease and the existence of cognitively resilient individuals despite significant pathological burden. More broadly, the proposed framework suggests a pattern-based therapeutic paradigm in which disease dynamics are guided toward favorable stable states rather than solely targeting the elimination of pathological proteins.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 0 minor

Summary. The manuscript adapts the Gray-Scott reaction-diffusion model to Aβ-Tau interactions in Alzheimer's disease. Using a Companion-Based Multi-Level Finite Element Method (CBMFEM) on 2D domains and anatomically realistic cortical surface meshes, numerical simulations identify multiple steady-state solutions that are classified into pattern phenotypes via principal component analysis and clustering. The central claim is that the coupled Aβ–Tau system admits numerous stable spatial patterns rather than a single pathological endpoint, providing a framework for AD heterogeneity and cognitively resilient individuals.

Significance. If the adapted model and its numerics hold, the work offers a mathematical explanation for why substantial pathology does not always produce dementia and suggests shifting from protein-elimination therapies to guiding dynamics toward favorable stable states. The use of realistic cortical meshes and systematic classification of patterns is a computational strength. However, the absence of explicit kinetic mapping or biological validation keeps the significance potential rather than demonstrated.

major comments (2)
  1. [Abstract] Abstract and implied Methods: the reaction terms are taken directly from the classic Gray-Scott autocatalytic form without a derivation or parameter mapping that connects feed/kill rates to measured rates of Aβ aggregation, Tau seeding, or clearance; the multiplicity of patterns could therefore be an artifact of the chosen nonlinearities rather than a generic feature of Aβ-Tau biology.
  2. [Abstract] Abstract: no equations, parameter values, stability analysis, or validation against biological data are provided, preventing assessment of whether the CBMFEM numerics support the claim of numerous biologically relevant stable states.

Simulated Author's Rebuttal

2 responses · 1 unresolved

We thank the referee for their constructive comments. We address each major comment below and indicate the revisions made to strengthen the manuscript.

read point-by-point responses

  1. Referee: [Abstract] Abstract and implied Methods: the reaction terms are taken directly from the classic Gray-Scott autocatalytic form without a derivation or parameter mapping that connects feed/kill rates to measured rates of Aβ aggregation, Tau seeding, or clearance; the multiplicity of patterns could therefore be an artifact of the chosen nonlinearities rather than a generic feature of Aβ-Tau biology.

    Authors: We acknowledge that the reaction terms follow the standard Gray-Scott form without a bottom-up derivation from measured kinetic rates, as comprehensive rate constants for the coupled Aβ-Tau processes remain incompletely characterized in the literature. The adaptation is presented as a minimal phenomenological model capable of generating diverse spatial patterns through autocatalytic and clearance-like terms, with motivation provided in the Introduction. The multiplicity of patterns is indeed a property of this nonlinear class, which we use to illustrate the potential for multiple stable states rather than claiming it as a generic biological feature. We have added a subsection in Methods discussing parameter choices and their analogies to aggregation and clearance processes. revision: partial

  2. Referee: [Abstract] Abstract: no equations, parameter values, stability analysis, or validation against biological data are provided, preventing assessment of whether the CBMFEM numerics support the claim of numerous biologically relevant stable states.

    Authors: Abstracts are kept concise by design and conventionally omit equations and parameter tables. The full manuscript details the adapted reaction-diffusion equations, the specific parameter values, the CBMFEM discretization on 2D and cortical meshes, and the numerical protocol of integrating to steady state to identify stable patterns. No analytical linear stability analysis is performed; stability is assessed via convergence in long-time simulations. We have revised the abstract to include a short reference to the model equations and the numerical classification of steady states. Direct biological validation lies outside the scope of this theoretical study. revision: yes

standing simulated objections not resolved
  • Absence of experimental or biological data validation for the identified patterns, which cannot be supplied in a purely computational modeling manuscript.

Circularity Check

0 steps flagged

No circularity; central claim rests on independent numerical simulations

full rationale

The paper adapts the Gray-Scott reaction-diffusion system and employs CBMFEM simulations on 2D domains and cortical meshes to generate and classify multiple steady-state patterns via PCA and clustering. The claim of numerous stable spatial patterns follows directly from these simulation outputs rather than from any self-definitional equations, fitted inputs renamed as predictions, or load-bearing self-citations. The derivation chain is self-contained against external benchmarks because the multiplicity result is produced by solving the adapted PDE system under stated initial/boundary conditions, with no reduction of the target conclusion to the model choice itself by construction.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

Abstract-only review provides no explicit free parameters, axioms, or invented entities; the central claim rests on the unstated assumption that the adapted Gray-Scott kinetics are biologically appropriate.

pith-pipeline@v0.9.1-grok · 5759 in / 1043 out tokens · 26103 ms · 2026-07-01T07:19:17.256777+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

71 extracted references · 1 canonical work pages

  1. [1]

    A robust and accurate solver for some nonlinear partial differential equations and tow applications.Physica 29 Scripta, 95(6):065212, 2020

    Mahmoud AE Abdelrahman and Hanan A Alkhidhr. A robust and accurate solver for some nonlinear partial differential equations and tow applications.Physica 29 Scripta, 95(6):065212, 2020

    2020

  2. [2]

    A data-driven study of alzheimer’s disease related amyloid and tau pathology progression.Brain, 146(12):4935–4948, 2023

    Leon M Aksman, Neil P Oxtoby, Marzia A Scelsi, Peter A Wijeratne, Alexandra L Young, Isadora Lopes Alves, Lyduine E Collij, Jacob W Vogel, Frederik Barkhof, Daniel C Alexander, et al. A data-driven study of alzheimer’s disease related amyloid and tau pathology progression.Brain, 146(12):4935–4948, 2023

    2023

  3. [3]

    Human amyloid-βsynthesis and clearance rates as measured in cerebrospinal fluid in vivo.Nature medicine, 12(7):856–861, 2006

    Randall J Bateman, Ling Y Munsell, John C Morris, Robert Swarm, Kevin E Yarasheski, and David M Holtzman. Human amyloid-βsynthesis and clearance rates as measured in cerebrospinal fluid in vivo.Nature medicine, 12(7):856–861, 2006

    2006

  4. [4]

    Alzheimer’s disease: a mathematical model for onset and progression

    Michiel Bertsch, Bruno Franchi, Norina Marcello, Maria Carla Tesi, and Andrea Tosin. Alzheimer’s disease: a mathematical model for onset and progression. Mathematical medicine and biology: a journal of the IMA, 34(2):193–214, 2017

    2017

  5. [5]

    Blinkov and Ilya I

    Samuil M. Blinkov and Ilya I. Glezer.The Human Brain in Figures and Tables: A Quantitative Handbook. Plenum Press, New York, 1968. Translated by Basil Haigh

    1968

  6. [6]

    Absence of cx3cr1 impairs the internalization of tau by microglia.Molecular neurodegeneration, 12(1):59, 2017

    Marta Bol´ os, Mar´ ıa Llorens-Mart´ ın, Juan Ram´ on Perea, Jer´ onimo Jurado- Arjona, Alberto R´ abano, F´ elix Hern´ andez, and Jes´ us Avila. Absence of cx3cr1 impairs the internalization of tau by microglia.Molecular neurodegeneration, 12(1):59, 2017

    2017

  7. [7]

    Neuropathological stageing of alzheimer-related changes.Acta neuropathologica, 82(4):239–259, 1991

    Heiko Braak and Eva Braak. Neuropathological stageing of alzheimer-related changes.Acta neuropathologica, 82(4):239–259, 1991

    1991

  8. [8]

    Synergy between amyloid-βand tau in alzheimer’s disease.Nature neuroscience, 23(10):1183–1193, 2020

    Marc Aurel Busche and Bradley T Hyman. Synergy between amyloid-βand tau in alzheimer’s disease.Nature neuroscience, 23(10):1183–1193, 2020

    2020

  9. [9]

    SIAM, 2002

    Philippe G Ciarlet.The finite element method for elliptic problems. SIAM, 2002

    2002

  10. [10]

    Cross and Pierre C

    Michael C. Cross and Pierre C. Hohenberg. Pattern formation outside of equilibrium.Reviews of Modern Physics, 65(3):851–1112, 1993. 30

    1993

  11. [11]

    Alzheimer’s disease drug development pipeline: 2024.Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 10(2):e12465, 2024

    Jeffrey Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Fonseca, and Feix- iong Cheng. Alzheimer’s disease drug development pipeline: 2024.Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 10(2):e12465, 2024

    2024

  12. [12]

    Uncover governing law of pathol- ogy propagation mechanism through a mean-field game.Advances in Neural Information Processing Systems, 38:95292–95314, 2026

    Tingting Dan, Zhihao Fan, and Guorong Wu. Uncover governing law of pathol- ogy propagation mechanism through a mean-field game.Advances in Neural Information Processing Systems, 38:95292–95314, 2026

    2026

  13. [13]

    Translational diffusion measured by pfg-nmr on full length and fragments of the alzheimer aβ (1–40) peptide

    Jens Danielsson, J¨ uri Jarvet, Peter Damberg, and Astrid Gr¨ aslund. Translational diffusion measured by pfg-nmr on full length and fragments of the alzheimer aβ (1–40) peptide. determination of hydrodynamic radii of random coil peptides of varying length.Magnetic Resonance in Chemistry, 40(13):S89–S97, 2002

    2002

  14. [14]

    John Wiley & Sons, 2012

    Gouri Dhatt, Emmanuel Lefran¸ cois, and Gilbert Touzot.Finite element method. John Wiley & Sons, 2012

    2012

  15. [15]

    Finite elements for the beltrami operator on arbitrary surfaces

    Gerhard Dziuk. Finite elements for the beltrami operator on arbitrary surfaces. In Partial differential equations and calculus of variations, pages 142–155. Springer, 2006

    2006

  16. [16]

    Finite element methods for surface pdes

    Gerhard Dziuk and Charles M Elliott. Finite element methods for surface pdes. Acta Numerica, 22:289–396, 2013

    2013

  17. [17]

    Freesurfer.Neuroimage, 62(2):774–781, 2012

    Bruce Fischl. Freesurfer.Neuroimage, 62(2):774–781, 2012

    2012

  18. [18]

    Cortical surface-based anal- ysis: Ii: inflation, flattening, and a surface-based coordinate system.Neuroimage, 9(2):195–207, 1999

    Bruce Fischl, Martin I Sereno, and Anders M Dale. Cortical surface-based anal- ysis: Ii: inflation, flattening, and a surface-based coordinate system.Neuroimage, 9(2):195–207, 1999

    1999

  19. [19]

    Prion-like spreading of alzheimer’s disease within the brain’s connectome.Journal of the Royal Society Interface, 16(159):20190356, 2019

    Sveva Fornari, Amelie Sch¨ afer, Mathias Jucker, Alain Goriely, and Ellen Kuhl. Prion-like spreading of alzheimer’s disease within the brain’s connectome.Journal of the Royal Society Interface, 16(159):20190356, 2019

    2019

  20. [20]

    Atypical and typical presentations of alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.Brain, 123(3):484–498, 2000

    Clare J Galton, Karalyn Patterson, John H Xuereb, and John R Hodges. Atypical and typical presentations of alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.Brain, 123(3):484–498, 2000. 31

    2000

  21. [21]

    New insights into atypical alzheimer’s disease in the era of biomarkers.The Lancet Neurology, 20(3):222–234, 2021

    Jonathan Graff-Radford, Keir XX Yong, Liana G Apostolova, Femke H Bouwman, Maria Carrillo, Bradford C Dickerson, Gil D Rabinovici, Jonathan M Schott, David T Jones, and Melissa E Murray. New insights into atypical alzheimer’s disease in the era of biomarkers.The Lancet Neurology, 20(3):222–234, 2021

    2021

  22. [22]

    Mathematical model on alzheimer’s disease

    Wenrui Hao and Avner Friedman. Mathematical model on alzheimer’s disease. BMC systems biology, 10(1):108, 2016

    2016

  23. [23]

    Companion-based multi-level finite ele- ment method for computing multiple solutions of nonlinear differential equations

    Wenrui Hao, Sun Lee, and Young Ju Lee. Companion-based multi-level finite ele- ment method for computing multiple solutions of nonlinear differential equations. Computers & Mathematics with Applications, 168:162–173, 2024

    2024

  24. [24]

    Optimal anti-amyloid-beta therapy for alzheimer’s disease via a personalized mathematical model.PLoS computational biology, 18(9):e1010481, 2022

    Wenrui Hao, Suzanne Lenhart, and Jeffrey R Petrella. Optimal anti-amyloid-beta therapy for alzheimer’s disease via a personalized mathematical model.PLoS computational biology, 18(9):e1010481, 2022

    2022

  25. [25]

    On pattern formation in the thermodynamically-consistent variational gray-scott model.Mathematical biosciences, 385:109453, 2025

    Wenrui Hao, Chun Liu, Yiwei Wang, and Yahong Yang. On pattern formation in the thermodynamically-consistent variational gray-scott model.Mathematical biosciences, 385:109453, 2025

    2025

  26. [26]

    Spatial pattern formation in reaction–diffusion models: a computational approach.Journal of mathematical biology, 80(1):521– 543, 2020

    Wenrui Hao and Chuan Xue. Spatial pattern formation in reaction–diffusion models: a computational approach.Journal of mathematical biology, 80(1):521– 543, 2020

    2020

  27. [27]

    John Hardy and Dennis J. Selkoe. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics.Science, 297(5580):353–356, 2002

    2002

  28. [28]

    Alzheimer’s disease: the amyloid cascade hypothesis.Science, 256(5054):184–185, 1992

    John A Hardy and Gerald A Higgins. Alzheimer’s disease: the amyloid cascade hypothesis.Science, 256(5054):184–185, 1992

    1992

  29. [29]

    Impaired glymphatic function and clearance of tau in an alzheimer’s disease model.Brain, 143(8):2576–2593, 2020

    Ian F Harrison, Ozama Ismail, Asif Machhada, Niall Colgan, Yolanda Ohene, Payam Nahavandi, Zeshan Ahmed, Alice Fisher, Soraya Meftah, Tracey K Mur- ray, et al. Impaired glymphatic function and clearance of tau in an alzheimer’s disease model.Brain, 143(8):2576–2593, 2020. 32

    2020

  30. [30]

    Amyloid-βplaques enhance alzheimer’s brain tau-seeded patholo- gies by facilitating neuritic plaque tau aggregation.Nature medicine, 24(1):29–38, 2018

    Zhuohao He, Jing L Guo, Jennifer D McBride, Sneha Narasimhan, Hyesung Kim, Lakshmi Changolkar, Bin Zhang, Ronald J Gathagan, Cuiyong Yue, Christopher Dengler, et al. Amyloid-βplaques enhance alzheimer’s brain tau-seeded patholo- gies by facilitating neuritic plaque tau aggregation.Nature medicine, 24(1):29–38, 2018

    2018

  31. [31]

    Jack, David A

    Clifford R. Jack, David A. Bennett, Kaj Blennow, and et al. Nia-AA research framework: toward a biological definition of Alzheimer’s disease.Alzheimer’s & Dementia, 14(4):535–562, 2018

    2018

  32. [32]

    Hypo- thetical model of dynamic biomarkers of the alzheimer’s pathological cascade

    Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, and John Q Trojanowski. Hypo- thetical model of dynamic biomarkers of the alzheimer’s pathological cascade. The Lancet Neurology, 9(1):119–128, 2010

    2010

  33. [33]

    Whitwell, Chadwick Ward, et al

    Clifford R Jack Jr, Matt A Bernstein, Nick C Fox, Paul Thompson, Gene Alexan- der, Danielle Harvey, Bret Borowski, Paula J Britson, Jennifer L. Whitwell, Chadwick Ward, et al. The alzheimer’s disease neuroimaging initiative (adni): Mri methods.Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in...

    2008

  34. [34]

    Single-molecule tracking of tau reveals fast kiss-and-hop inter- action with microtubules in living neurons.Molecular biology of the cell, 25(22):3541–3551, 2014

    Dennis Janning, Maxim Igaev, Frederik S¨ undermann, J¨ org Br¨ uhmann, Oliver Beutel, J¨ urgen J Heinisch, Lidia Bakota, Jacob Piehler, Wolfgang Junge, and Roland Brandt. Single-molecule tracking of tau reveals fast kiss-and-hop inter- action with microtubules in living neurons.Molecular biology of the cell, 25(22):3541–3551, 2014

    2014

  35. [35]

    Parameter-robust mul- tiphysics algorithms for biot model with application in brain edema simulation

    Guoliang Ju, Mingchao Cai, Jingzhi Li, and Jing Tian. Parameter-robust mul- tiphysics algorithms for biot model with application in brain edema simulation. Mathematics and computers in simulation, 177:385–403, 2020

    2020

  36. [36]

    Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.Nature, 501(7465):45–51, 2013

    Mathias Jucker and Lary C Walker. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.Nature, 501(7465):45–51, 2013. 33

    2013

  37. [37]

    Springer Science & Business Media, 2013

    Jens Lang.Adaptive multilevel solution of nonlinear parabolic PDE systems: theory, algorithm, and applications, volume 16. Springer Science & Business Media, 2013

    2013

  38. [38]

    Optimal control for anti-abeta treatment in alzheimer’s disease using a reaction-diffusion model.arXiv preprint arXiv:2504.07913, 2025

    Sun Lee, Chiu-Yen Kao, Zhiyuan Li, Tingting Dan, Guorong Wu, and Wenrui Hao. Optimal control for anti-abeta treatment in alzheimer’s disease using a reaction-diffusion model.arXiv preprint arXiv:2504.07913, 2025

    work page arXiv 2025

  39. [39]

    Parallel subspace correction methods for semico- ercive and nearly semicoercive convex optimization with applications to nonlinear pdes.Mathematics of Computation, 2025

    Young-Ju Lee and Jongho Park. Parallel subspace correction methods for semico- ercive and nearly semicoercive convex optimization with applications to nonlinear pdes.Mathematics of Computation, 2025

    2025

  40. [40]

    Young-Ju Lee and Jinchao Xu. New formulations, positivity preserving discretiza- tions and stability analysis for non-newtonian flow models.Computer methods in applied mechanics and engineering, 195(9-12):1180–1206, 2006

    2006

  41. [41]

    Stable finite element dis- cretizations for viscoelastic flow models

    Young-Ju Lee, Jinchao Xu, and Chen-Song Zhang. Stable finite element dis- cretizations for viscoelastic flow models. InHandbook of numerical analysis, volume 16, pages 371–432. Elsevier, 2011

    2011

  42. [42]

    A reaction-diffusion model of human brain development.PLoS computational biology, 6(4):e1000749, 2010

    Julien Lef` evre and Jean-Fran¸ cois Mangin. A reaction-diffusion model of human brain development.PLoS computational biology, 6(4):e1000749, 2010

    2010

  43. [43]

    Consistent reconstruction of cortical surfaces from longitudinal brain mr images.Neuroimage, 59(4):3805–3820, 2012

    Gang Li, Jingxin Nie, Guorong Wu, Yaping Wang, Dinggang Shen, Alzheimer’s Disease Neuroimaging Initiative, et al. Consistent reconstruction of cortical surfaces from longitudinal brain mr images.Neuroimage, 59(4):3805–3820, 2012

    2012

  44. [44]

    A robust and effi- cient method for steady state patterns in reaction–diffusion systems.Journal of computational physics, 231(15):5062–5077, 2012

    Wing-Cheong Lo, Long Chen, Ming Wang, and Qing Nie. A robust and effi- cient method for steady state patterns in reaction–diffusion systems.Journal of computational physics, 231(15):5062–5077, 2012

    2012

  45. [45]

    Springer, 2003

    James Dickson Murray and James Dickson Murray.Mathematical biology: II: spatial models and biomedical applications, volume 18. Springer, 2003

    2003

  46. [46]

    Tau pet patterns mirror clinical and neuroanatom- ical variability in alzheimer’s disease.Brain, 139(5):1551–1567, 2016

    Rik Ossenkoppele, Daniel R Schonhaut, Michael Sch¨ oll, Samuel N Lockhart, Nagehan Ayakta, Suzanne L Baker, James P O’Neil, Mustafa Janabi, Andreas 34 Lazaris, Averill Cantwell, et al. Tau pet patterns mirror clinical and neuroanatom- ical variability in alzheimer’s disease.Brain, 139(5):1551–1567, 2016

    2016

  47. [47]

    Complex patterns in a simple system.Science, 261(5118):189– 192, 1993

    John E Pearson. Complex patterns in a simple system.Science, 261(5118):189– 192, 1993

    1993

  48. [48]

    Compu- tational causal modeling of the dynamic biomarker cascade in alzheimer’s disease

    Jeffrey R Petrella, Wenrui Hao, Adithi Rao, and P Murali Doraiswamy. Compu- tational causal modeling of the dynamic biomarker cascade in alzheimer’s disease. Computational and mathematical methods in medicine, 2019(1):6216530, 2019

    2019

  49. [49]

    Personalized computational causal modeling of the alzheimer disease biomarker cascade.The journal of prevention of Alzheimer’s disease, 11(2):435–444, 2024

    Jeffrey R Petrella, J Jiang, K Sreeram, S Dalziel, PM Doraiswamy, W Hao, and Alzheimer’s Disease Neuroimaging Initiative. Personalized computational causal modeling of the alzheimer disease biomarker cascade.The journal of prevention of Alzheimer’s disease, 11(2):435–444, 2024

    2024

  50. [50]

    Price and John C

    Joseph L. Price and John C. Morris. Neuropathology of nondemented aging. Current Alzheimer Research, 6(1):33–44, 2009

    2009

  51. [51]

    Alzheimer’s disease.New England Journal of Medicine, 362(4):329–344, 2010

    Henry W Querfurth and Frank M LaFerla. Alzheimer’s disease.New England Journal of Medicine, 362(4):329–344, 2010

    2010

  52. [52]

    Data-driven modeling of amyloid-β targeted antibodies for alzheimer’s disease.NPJ systems biology and applications, 11(1):134, 2025

    Kobra Rabiei, Jeffrey R Petrella, Suzanne Lenhart, Chun Liu, Wenrui Hao, and Alzheimer Disease Neuroimaging Initiative. Data-driven modeling of amyloid-β targeted antibodies for alzheimer’s disease.NPJ systems biology and applications, 11(1):134, 2025

    2025

  53. [53]

    A network diffusion model of disease progression in dementia.Neuron, 73(6):1204–1215, 2012

    Ashish Raj, Amy Kuceyeski, and Michael Weiner. A network diffusion model of disease progression in dementia.Neuron, 73(6):1204–1215, 2012

    2012

  54. [54]

    Tau kinetics in neurons and the human central nervous system.Neuron, 97(6):1284–1298, 2018

    Chihiro Sato, Nicolas R Barth´ elemy, Kwasi G Mawuenyega, Bruce W Patterson, Brian A Gordon, Jennifer Jockel-Balsarotti, Melissa Sullivan, Matthew J Crisp, Tom Kasten, Kristopher M Kirmess, et al. Tau kinetics in neurons and the human central nervous system.Neuron, 97(6):1284–1298, 2018

    2018

  55. [55]

    35 Alzheimer’s disease.The Lancet, 397(10284):1577–1590, 2021

    Philip Scheltens, Bart De Strooper, Miia Kivipelto, Henne Holstege, Gael Ch´ etelat, Charlotte E Teunissen, Jeffrey Cummings, and Wiesje M Van der Flier. 35 Alzheimer’s disease.The Lancet, 397(10284):1577–1590, 2021

    2021

  56. [56]

    Dennis J. Selkoe. The molecular pathology of Alzheimer’s disease.Neuron, 6(4):487–498, 1991

    1991

  57. [57]

    The amyloid hypothesis of alzheimer’s disease at 25 years.EMBO molecular medicine, 8(6):595–608, 2016

    Dennis J Selkoe and John Hardy. The amyloid hypothesis of alzheimer’s disease at 25 years.EMBO molecular medicine, 8(6):595–608, 2016

    2016

  58. [58]

    Sperling, Paul S

    Reisa A. Sperling, Paul S. Aisen, Laurel A. Beckett, and et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.Alzheimer’s & Dementia, 7(3):280–292, 2011

    2011

  59. [59]

    What is cognitive reserve? theory and research application of the reserve concept.Journal of the International Neuropsychological Society, 8(3):448–460, 2002

    Yaakov Stern. What is cognitive reserve? theory and research application of the reserve concept.Journal of the International Neuropsychological Society, 8(3):448–460, 2002

    2002

  60. [60]

    Diffusion in brain extracellular space

    Eva Sykov´ a and Charles Nicholson. Diffusion in brain extracellular space. Physiological reviews, 88(4):1277–1340, 2008

    2008

  61. [61]

    Phases of aβ- deposition in the human brain and its relevance for the development of ad

    Dietmar R Thal, Udo Ru ¨b, Mario Orantes, and Heiko Braak. Phases of aβ- deposition in the human brain and its relevance for the development of ad. Neurology, 58(12):1791–1800, 2002

    2002

  62. [62]

    Alan M. Turing. The chemical basis of morphogenesis.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 237(641):37–72, 1952

    1952

  63. [63]

    Four distinct trajectories of tau deposition identified in alzheimer’s disease.Nature medicine, 27(5):871–881, 2021

    Jacob W Vogel, Alexandra L Young, Neil P Oxtoby, Ruben Smith, Rik Ossenkop- pele, Olof T Strandberg, Renaud La Joie, Leon M Aksman, Michel J Grothe, Yasser Iturria-Medina, et al. Four distinct trajectories of tau deposition identified in alzheimer’s disease.Nature medicine, 27(5):871–881, 2021

    2021

  64. [64]

    Learning patient-specific spatial biomarker dynamics via operator learning for alzheimer’s disease progression.npj Systems Biology and 36 Applications, 2026

    Jindong Wang, Yutong Mao, Xiao Liu, Wenrui Hao, and Alzheimer’s Disease Neu- roimaging Initiative. Learning patient-specific spatial biomarker dynamics via operator learning for alzheimer’s disease progression.npj Systems Biology and 36 Applications, 2026

    2026

  65. [65]

    Neurodetour: A neural pathway transformer for uncovering structural-functional coupling mechanisms in human connectome.Medical Image Analysis, page 103931, 2026

    Ziquan Wei, Tingting Dan, Jiaqi Ding, Paul J Laurienti, and Guorong Wu. Neurodetour: A neural pathway transformer for uncovering structural-functional coupling mechanisms in human connectome.Medical Image Analysis, page 103931, 2026

    2026

  66. [66]

    de Rooij, and et al

    Johannes Weickenmeier, Hanieh Joodaki, R. de Rooij, and et al. Brain stiffness increases with myelin content and decreases with Alzheimer’s disease pathology. Acta Biomaterialia, 95:263–273, 2019

    2019

  67. [67]

    Johannes Weickenmeier, Mathias Jucker, Alain Goriely, and Ellen Kuhl. A physics-based model explains the prion-like features of neurodegeneration in alzheimer’s disease, parkinson’s disease, and amyotrophic lateral sclerosis.Journal of the Mechanics and Physics of Solids, 124:264–281, 2019

    2019

  68. [68]

    Algebraic multigrid methods.Acta Numerica, 26:591–721, 2017

    Jinchao Xu and Ludmil Zikatanov. Algebraic multigrid methods.Acta Numerica, 26:591–721, 2017

    2017

  69. [69]

    Analysis of in vivo turnover of tau in a mouse model of tauopathy.Molecular neurodegeneration, 10(1):55, 2015

    Kaoru Yamada, Tirth K Patel, Katja Hochgr¨ afe, Thomas E Mahan, Hong Jiang, Floy R Stewart, Eva-Maria Mandelkow, and David M Holtzman. Analysis of in vivo turnover of tau in a mouse model of tauopathy.Molecular neurodegeneration, 10(1):55, 2015

    2015

  70. [70]

    Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia.The FEBS Journal, 291(15):3499–3520, 2024

    Chang Jae Yoo, Youngtae Choi, Eugene Bok, Yuxi Lin, Mookyung Cheon, Young- Ho Lee, and Jaekwang Kim. Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia.The FEBS Journal, 291(15):3499–3520, 2024

    2024

  71. [71]

    Data-driven causal model discovery and personalized prediction in alzheimer’s disease.NPJ digital medicine, 5(1):137, 2022

    Haoyang Zheng, Jeffrey R Petrella, P Murali Doraiswamy, Guang Lin, Wen- rui Hao, and Alzheimer’s Disease Neuroimaging Initiative. Data-driven causal model discovery and personalized prediction in alzheimer’s disease.NPJ digital medicine, 5(1):137, 2022. 37

    2022